AGP Executive Report
Last update: 11 hours agoCompliance: Cannabis brands face risks beyond lab testing, with packaging, labels, advertising, social media and budtender claims all potential sources of regulatory trouble. Local Licensing: Menominee voters will decide whether to expand the city’s cannabis-store cap from nine to 13, reopening a debate after earlier votes favored the lower limit. Federal Rules: The DEA has begun registering more than 900 medical cannabis dispensaries, while businesses await guidance on possible tax relief and are warned to source products from federally registered companies. Hemp Market: Proposed import tariffs and testing rules, alongside an approaching federal deadline for hemp-derived THC products, add uncertainty for businesses. Industry Results: Tilray posted record quarterly revenue of $257 million, but cannabis sales fell 13% as beverage growth drove the gains. New Markets: Nepal’s Supreme Court has directed the government to create rules for controlled cannabis cultivation and production for medical, scientific and industrial uses.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
